Skip to content
inentertainment.co.uk
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Nxera Pharma
Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing
May 24, 2026
Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology
May 24, 2026
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026
May 22, 2026
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
April 20, 2026
Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea
March 4, 2026
Nxera Pharma Webinar Presentation for FY2025 Financial Results
January 27, 2026
Nxera Pharma Establishes Metabolic Advisory Council to Advance Next-Generation Therapies for Obesity and Metabolic Disorders
January 20, 2026
←
Previous Page
1
2